Financial Statements and Related Announcement::Full Yearly Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
29-May-2021 01:31:24
Status
New
Announcement Sub Title
Full Yearly Results
Announcement Reference
SG210529OTHR4MSX
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
28/05/2021 00:00:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Outcome of the Board Meeting May 28, 2021

Additional Details

For Financial Period Ended
31/03/2021

Attachments

SGX_NSE_RESULT_28052021_122.pdf
Total size =22038K